Amgen
This role involves contributing to Inflammation discovery programs by planning project tasks, generating experimental data, and applying computational and AI-enabled approaches to deepen understanding of disease biology. The position requires managing defined program components, developing scientific expertise, and communicating data-driven insights to advance project decisions. The successful candidate will collaborate across functions to support target discovery and therapeutic hypothesis refinement.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Principal Scientist, Integrated Computational and Experimental Inflammation Discovery
Amgen
Associate Director Computational Biology, Cardio-Renal-Metabolic diseases
Digital Biology
Scientist I, Neuroimmunology, Target Validation and Drug Discovery
Valo Health
Principal or Senior Principal Scientist Computational Drug Discovery
Zealand Pharma
Post Doctoral Scientist (IHB) - Computational Immunology
Roche
Senior Scientist, Drug Discovery Biology (Target Biology & MoA)
Novartis